Medtronic stock fell 1.00 percent as MiniMed deadline nears

Published on 10/07/2026 at 13:26 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Medtronic stock faces a MiniMed exchange deadline on October 9, with a 7 percent discount and a 4.5939 share cap. Fiscal Q1 revenue reached USD 9.76 billion, up 13.7 percent year over year.

Editorialfoto eines Trading-Floors mit Händlern und Kursdiagrammen im Hintergrund — Medtronic plc (ISIN IE00BTN1Y115) Börsen-Editorial zeigt Trading-Floor der NYSE mit Kursdiagrammen im Hintergrund lebhaft, Illustration mit AI erstellt.

Medtronic plc (ISIN IE00BTN1Y115) was last at USD 87.09 on the NYSE on October 6, 2026 at 4:00 p.m. ET, down 1.00 percent from the prior close. The central corporate event is the MiniMed exchange offer, which reaches its scheduled expiration on October 9, 2026.

MiniMed separation reaches deadline

According to Medtronic on September 14, 2026, shareholders can exchange Medtronic ordinary shares for MiniMed shares in a transaction intended to separate at least 80.1 percent of MiniMed Group. The offer applies a 7 percent discount and caps the exchange at 4.5939 MiniMed shares for each Medtronic ordinary share accepted.

The terms create a defined near-term reference point for Medtronic stock. For every USD 100 of Medtronic shares accepted, the offer describes USD 107.53 of MiniMed stock if the upper limit does not reduce the allocation, while proration remains possible if the offer is oversubscribed.

Quarterly beat supports valuation

MarketBeat reported on October 3, 2026 that Medtronic delivered adjusted fiscal Q1 2027 EPS of USD 1.45 against a USD 1.39 consensus estimate. Revenue reached USD 9.76 billion, up 13.7 percent from the comparable quarter, and exceeded the USD 9.55 billion estimate.

The earnings comparison matters because the share price remains below its yearly peak. Medtronic stock was USD 19.24 below its 52-week high of USD 106.33 on October 6, 2026, a gap of 18.1 percent, while the 52-week low was USD 73.31.

Analysts see higher value

Markets Insider reported on October 5, 2026 that Citi maintained a Buy rating with a USD 110.00 price target. The same report cited a Moderate Buy consensus and an average target of USD 103.41, implying 18.7 percent above the October 6 price of USD 87.09.

A separate MarketBeat update on October 6, 2026 counted 19 Buy ratings and nine Hold ratings, with a Moderate Buy consensus and a USD 103.92 average target. The difference between the two published averages reflects the sensitivity of consensus measures to their analyst panels and update timing.

Stock trades below yearly high

Medtronic stock had a market capitalization of USD 111.5 billion and traded between USD 86.44 and USD 88.50 on October 6, 2026. The next dated decision point is the October 9 exchange-offer expiration, while the final exchange ratio is scheduled for release by 9:00 a.m. ET on the preceding trading day under the offer terms.